AXA’s alternative assets investment business is looking to life sciences, logistics and residential for most of its dealmaking this year.
AXA IM Alts said it expected “the bulk” of its 2022 investments to be in “conviction asset classes” as well as repositioning office assets.
The company competed almost €11bn (£9.2bn) of transactions last year, including €8.7bn of acquisitions and €2.1bn of disposals. Its logistics and industrials portfolio doubled in size during the year to €10.7bn, with the sector accounting for almost half of its transactions by value.
Isabelle Scemama, global head of AXA IM Alts, said: “Anticipating the trends driving each asset class will again be key for 2022. Within each sector there is a wide gap in value between premium and non-premium assets. We are being disciplined and selective, investing, developing and repositioning assets to deliver a premium portfolio that caters to post-pandemic trends in demand, and which will allow us to continue to create long-term value on behalf of investors.”
To send feedback, e-mail tim.burke@eg.co.uk or tweet @_tim_burke or @EGPropertyNews
